Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Change In Receivables?

Jiangsu Jibeier Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Jiangsu Jibeier Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Jiangsu Jibeier Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-138.1 Mil. It means Jiangsu Jibeier Pharmaceutical Co's Accounts Receivable increased by ¥138.1 Mil from Dec. 2022 to Dec. 2023 .

Jiangsu Jibeier Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥207.4 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Jiangsu Jibeier Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 97.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Jiangsu Jibeier Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥700.8 Mil.

Jiangsu Jibeier Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Change In Receivables Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-21.91

-57.21

42.96

-72.08

-138.14

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Jiangsu Jibeier Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Jiangsu Jibeier Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	207.413	/	194.231	*	91
=	97.44

2. In Ben Graham's calculation of liquidation value, Jiangsu Jibeier Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Jiangsu Jibeier Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	777.846	-	247.66	+	0.75 * 207.413	+	0.5 * 30.151
=	700.8

Jiangsu Jibeier Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000

Website

http://www.jibeier.com.cn

Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.

Executives

Wu Ying	senior management
Zhang Chun	Director
Zhao Suo Fu	senior management
Li Hai Dao	Core technical personnel
Di Jian Zhong	senior management
Qin Xu Feng	Core technical personnel
Wu Xiu Gen	Core technical personnel
Yu Xin Jun	Directors, senior managers
Hu Tao	Director

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Headlines

No Headlines